When should an HIV test be done after Post-Exposure Prophylaxis (PEP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

HIV Testing After Post-Exposure Prophylaxis (PEP)

HIV testing should be performed at 4-6 weeks after starting PEP and again at 12 weeks after starting PEP (8 weeks after completing PEP) using both laboratory-based antigen/antibody tests and nucleic acid tests to definitively rule out HIV infection. 1, 2

Recommended Testing Schedule

Initial Testing

  • Baseline HIV testing should be performed before initiating PEP using a rapid or laboratory-based antigen/antibody test 1
  • PEP should not be delayed while waiting for test results 1

Follow-up Testing

  • First follow-up test: 4-6 weeks after starting PEP (within 2 weeks of completing the 28-day course)

    • Should include both laboratory-based antigen/antibody test AND nucleic acid test (NAT) 1, 2
    • This timing helps identify HIV infection in persons who didn't complete or adhere to PEP 2
  • Final follow-up test: 12 weeks after starting PEP (8 weeks after completing PEP)

    • Should include both laboratory-based antigen/antibody test AND nucleic acid test (NAT) 1, 2
    • This timing is based on data about antiretroviral washout time and the window period of HIV tests 1

Rationale for Testing Approach

  1. Why both types of tests are needed:

    • Antiretroviral medications taken as PEP can suppress HIV viral load, delay seroconversion, and decrease the ability to detect HIV infection 1, 2
    • Using both laboratory-based Ag/Ab tests and NAT improves sensitivity for detecting HIV infection 1
  2. Why oral fluid tests are not recommended:

    • Oral fluid-based rapid HIV tests are less sensitive for detecting acute or recent infection than blood tests 1, 2

Special Considerations

  • The 4-6 week test may be omitted for individuals who:

    • Started PEP within 24 hours of exposure
    • Were adherent to the complete 28-day PEP course
    • Are not considering starting PrEP 1, 2
  • For patients transitioning to PrEP:

    • The 4-6 week follow-up visit is an appropriate time to assess for PrEP indications 1, 2
    • Patients starting PrEP before the final 12-week HIV test should be counseled about the possibility of false-negative results 2

Historical Context

While older guidelines (2001) recommended HIV testing for at least 6 months post-exposure 1, the most recent CDC recommendations (2025) have shortened this to 12 weeks based on improved understanding of antiretroviral washout times and test window periods 1, 2.

Clinical Implications

  • PEP efficacy is high when taken as prescribed, with studies showing extremely low failure rates (0.04%) 3
  • Most seroconversions after PEP are due to continued high-risk behavior rather than PEP failure 3
  • Adherence to the full 28-day PEP regimen is critical for effectiveness, with studies showing approximately 70% adherence rates 3

By following this testing schedule, clinicians can effectively monitor for HIV infection after PEP while minimizing unnecessary testing and maximizing the likelihood of detecting any potential infections.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

HIV Post-Exposure Prophylaxis (nPEP) Follow-up Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.